TW200739077A - Method of prognostic expectation for acute coronary syndromes - Google Patents

Method of prognostic expectation for acute coronary syndromes

Info

Publication number
TW200739077A
TW200739077A TW095148141A TW95148141A TW200739077A TW 200739077 A TW200739077 A TW 200739077A TW 095148141 A TW095148141 A TW 095148141A TW 95148141 A TW95148141 A TW 95148141A TW 200739077 A TW200739077 A TW 200739077A
Authority
TW
Taiwan
Prior art keywords
acute coronary
coronary syndromes
prognostic
expectation
prognostic expectation
Prior art date
Application number
TW095148141A
Other languages
English (en)
Inventor
Noriaki Kume
Goro Kominami
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of TW200739077A publication Critical patent/TW200739077A/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
TW095148141A 2005-12-22 2006-12-21 Method of prognostic expectation for acute coronary syndromes TW200739077A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005370030 2005-12-22

Publications (1)

Publication Number Publication Date
TW200739077A true TW200739077A (en) 2007-10-16

Family

ID=38188670

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095148141A TW200739077A (en) 2005-12-22 2006-12-21 Method of prognostic expectation for acute coronary syndromes

Country Status (9)

Country Link
US (1) US20110045504A1 (zh)
EP (1) EP1975614A4 (zh)
JP (1) JPWO2007072896A1 (zh)
KR (1) KR20080078675A (zh)
CN (1) CN101341406A (zh)
AU (1) AU2006328412B2 (zh)
CA (1) CA2639624A1 (zh)
TW (1) TW200739077A (zh)
WO (1) WO2007072896A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008013257A1 (fr) 2006-07-28 2008-01-31 Shionogi & Co., Ltd. Anticorps monoclonal dirigé contre le lox-1 soluble
JP6039879B2 (ja) * 2007-11-05 2016-12-07 ノルディック・ビオサイエンス・エー／エスＮｏｒｄｉｃ Ｂｉｏｓｃｉｅｎｃｅ Ａ／Ｓ Ｃｖｄリスク評価のための生化学マーカー
KR101984247B1 (ko) * 2012-03-15 2019-05-30 삼성전자 주식회사 관상동맥석회화 수준 변화 예측장치 및 예측방법
CN107860913B (zh) * 2017-09-29 2020-06-05 北京市心肺血管疾病研究所 区分主动脉瘤/主动脉夹层和急性肺栓塞的血清标志物及其应用
RU2747693C1 (ru) * 2020-06-18 2021-05-12 федеральное государственное бюджетное образовательное учреждение высшего образования "Приволжский исследовательский медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО "ПИМУ" Минздрава России) Способ прогнозирования неблагоприятных исходов на период до 12 месяцев у пациентов с острым коронарным синдромом

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5989811A (en) * 1994-09-29 1999-11-23 Urocor, Inc. Sextant core biopsy predictive mechanism for non-organ confined disease status
US5750345A (en) * 1995-10-31 1998-05-12 Evanston Hospital Corporation Detection of human α-thalassemia mutations and their use as predictors of blood-related disorders
EP1418234A4 (en) * 2000-03-02 2005-03-16 Abgenix Inc HUMAN MONOCLONAL ANTIBODIES DIRECTED AGAINST OXIDIZED LDL RECEPTORS AND THEIR MEDICAL USE
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
EP1369128A1 (en) * 2002-06-07 2003-12-10 Procorde GmbH Inhibitors of glycoprotein VI and their therapeutic use
JP2005252383A (ja) * 2004-03-01 2005-09-15 Matsushita Electric Ind Co Ltd メディアアクセス制御方式および局
JP4575692B2 (ja) * 2004-03-25 2010-11-04 日本メジフィジックス株式会社 Ｌｏｘ−１診断用薬剤

Also Published As

Publication number Publication date
CN101341406A (zh) 2009-01-07
KR20080078675A (ko) 2008-08-27
AU2006328412A1 (en) 2007-06-28
EP1975614A1 (en) 2008-10-01
WO2007072896A1 (ja) 2007-06-28
EP1975614A4 (en) 2010-06-09
AU2006328412B2 (en) 2011-11-24
CA2639624A1 (en) 2007-06-28
JPWO2007072896A1 (ja) 2009-06-04
US20110045504A1 (en) 2011-02-24

Similar Documents

Publication Publication Date Title
IN2013CN01129A (zh)
TW200739077A (en) Method of prognostic expectation for acute coronary syndromes
DK1761651T3 (da) MNRA-forhold i urinsedimenter og/eller urin som en prognostisk og/eller teranostisk markør for prostatakræft
HK1105454A1 (en) Determination of neutrophil gelatinase-associated lipocalin (ngal) as a diagnostic marker for renal disorders
ES2484142T3 (es) Diagnóstico molecular y clasificación del melanoma maligno
DE602006001278D1 (de) Messinstrument für Oberflächenprofile
DE602006002809D1 (de) Verfahren zur erkennung eines ovarialkarzinoms
NO20090939L (no) Anordning og fremgangsmate for a beregne belastninger og bevegelse av deler nede i bronnen
MX2013001042A (es) Biomarcadores de cancer pancreatico y usos de los mismos.
DE602006021768D1 (de) Nachweis von lysophosphatidylcholin für die prognose oder diagnose eines systemischen entzündungszustands
WO2010006048A3 (en) Gene expression profiling for predicting the survivability of prostate cancer subjects
DK1492440T3 (da) Fremgangsmåde til opnåelse af en diagnose og prognose for maligne sygdomme
NO20092109L (no) Bestemmelse av elektrisk felt basert pa malinger fra en magnetisk feltsensor for undersokelse av en underjordisk struktur
ATE391284T1 (de) Verwendung von oberflächenmesssonden
WO2006063133A3 (en) Biomarker for inflammatory bowel disease
WO2009078950A3 (en) Method of determing excretion of sodium and other analytes
WO2007146668A3 (en) Use of imp3 as a prognostic marker for cancer
PL2021794T3 (pl) Zastosowanie białka S100A 12 jako markera raka okrężnicy i odbytnicy
WO2008128043A3 (en) Diagnostic and prognostic methods for renal cell carcinoma
WO2011154698A3 (en) Method,array and use thereof
ATE458196T1 (de) Verfahren zum apoptosenachweis
WO2013062261A3 (en) Newly identified colon cancer marker and diagnostic kit using the same
WO2007075672A3 (en) Prognostic cancer markers
AU2010209763A8 (en) Biomarker for diagnosis, prediction and/or prognosis of acute heart failure and uses thereof
DE602007011542D1 (de) Schätzsystem für einen Indikator für Körperzusammensetzungen